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Abstract: Objective: HIV gp120 is a pleiotropic protein present in the plasma and tissues of HIV-infected patients, which 
affects a variety of homeostatic functions. In this report, we examine the mechanism of how gp120 blocks CD4 T cells 
from migrating towards SDF-1. 
Methods: In vitro treatment of primary CD4 T cells with CXCR4 tropic gp120, SDF, and measurement of chemotaxis and 
cell signaling. 
Results: gp120 signaling through CD4 receptor and Lck are required for its ability to inhibit chemotaxis induced by SDF, 
as demonstrated by CD4 receptor decoys, Lck inhibitors, as well as cells deficient in Lck, in which Lck expression is 
restored. Blocking Lck abrogates the ability of CXCR4 tropic gp120 to antagonize SDF-1induced chemotaxis. This 
inhibition is associated with cofilin phosphorylation, thereby providing a potential mechanism. 
Conclusion: We conclude that the ability of gp120 to inhibit SDF-1induced chemotaxis is mediated by the CD4 
receptor and Lck signaling, potentially by promoting cofilin phosphorylation. 
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INTRODUCTION 
  During HIV infection, T cell homing is altered and 
peripheral T cell number is reduced while patients develop 
peripheral lymphadenopathy. Histology of these lymph 
nodes demonstrates accumulation of CD4 T cells, which is 
felt to favor viral dissemination and infection of CD4 T cells 
[1]. The signals which promote abnormal T cell trafficking 
are only partially understood. gp120 blocks CXCL8 induced 
chemotaxis, as well as sphingosine 1 phosphate mediated 
egress of T cells in a herbimycin A-dependent manner, 
suggesting that these effects are mediated by Lck [2]. 
Several groups have also reported that gp120 promotes non 
responsiveness to SDF-1 (CXCL12)-induced chemotaxis in 
B cells [3], monocytes [4] and T cells [5], putatively by 
downregulating CXC chemokine receptor 4 (CXCR4) 
expression. 
  HIV-1 uses CD4 and one of several possible seven 
transmembrane G protein coupled receptors for cell entry. 
HIV fusion with targets cells occurs through the interaction 
of envelope glycoprotein gp120 with the CD4 receptor that 
results in conformational changes allowing the binding of 
gp120 to CXCR4 [6-9] in the case of T tropic virus. gp120 
binding leads to downregulation of CXCR4 expression [5], 
which has been attributed as the cause of reduced chemotaxis 
in response to SDF-1 [3, 5]. CXCR4 downregulation 
occurs as a result of gp120 interaction with CD4 and Lck 
activation [10] leading to CXCR4 phosphorylation and 
receptor internalization [5]. 
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  One early cellular response of T cells stimulated with 
SDF-1 is actin cytoskeleton reorganization [11] which is 
regulated by cofilin. Active cofilin functions to depolymerize 
actin [12, 13] and is required for efficient chemotaxis, 
wherein cycles of actin polymerization and depolymerization 
lead to cell migration. The activity of cofilin is negatively 
regulated by serine/threonine phosphorylation by LIM 
kinase1 (LIMK1) through phosphorylation of cofilin at Ser-3 
[14] which renders cofilin incapable of binding actin. In the 
current report, we examine the mechanism by which gp120 
causes non-responsiveness to SDF-1induced chemotaxis 
in T cells, specifically examining the role of Lck signaling, 
and its potential effects on cofilin. 
MATERIALS AND METHODS 
Cell Culture and Reagents 
 CD4
  T cells were isolated from the blood of healthy 
volunteer donors by using RossetteSep CD4 enrichment 
cocktail in accordance with the manufacture’s protocol 
(StemCell Technologies, Vancouver, British Columbia, 
Canada). The remaining cell population was repeatedly 
found to be 98% CD4 T cells as determined by flow 
cytometry. CD4 T cells were maintained in RPMI 1640 
supplemented with 10% fetal bovine serum (Invitrogen, 
Carlsbad, CA), 2 mM L-glutamine, and antibiotics 
(penicillin 100 U/ml, streptomycin 100 μg/ml) at 0.5x10
6 
cells/ml. CD4 T cells were incubated with HIV-1 X4 
gp120IIIB (Immuno Diagnostics, Inc. Woburn, MA) or 
gp120 IIIB pretreated with soluble CD4 (1:3) (Immuno 
Diagnostics, Inc. Woburn, MA) at concentrations of 1 
μg/ml/2x10
6 cells for indicated time at 37°C. 
 SDF-1 was purchased from R&D Systems 
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from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-
phospho-Erk (T280/Y282), anti-Erk1/2, anti-phospho-cofilin 
(S3), anti-phospho-Akt (Ser473), anti-phospho-Src (Y416) 
and anti-cofilin antibodies were purchased from Cell 
Signaling Technology (Beverly, MA). Fluorescent (Oregon 
Green 514) phalloidin was purchased from Invitrogen 
(Carlsbad, CA). Anti-CXCR4-PE and anti-CD4-PE were 
purchased from BD Biosciences (San Jose, CA). Leupeptin, 
aprotinin and pepstatin A were obtained from Boehringer-
Mannheim (Indianapolis, IN). 
Cell Extract Preparation, Immunoblotting 
  To obtain total cellular proteins, cells were washed with 
cold phosphate-buffered saline (PBS), resuspended in a 
modified whole-cell extract buffer [15] [40 mM Tris-HCl 
(pH=8), 0.25 M NaCl, 1% Triton X-100, 6 mM EDTA, 6 
mM EGTA, 10 mM para-nitrophenyl phosphate, 10 mM -
glycerophosphate, 300 μM sodium orthovanadate, 1 mM 
DTT, 2 μM phenylmethylsulfonyl fluoride (PMSF), 
aprotinin at 10 μg/ml, leupeptin at 1 μg/ml, pepstatin 1 
μg/ml] and centrifuged at 1200 x g for 15 min at 4°C. The 
resultant supernatant contains total cellular protein. The 
amount of cellular protein present in the clarified supernatant 
was calculated by using the Bio-Rad (Hercules, CA) protein 
assay. 
  For Western immunoblots, equal amounts of whole cell 
extract (WCE) were loaded and separated by SDS-
polyacrylamide gel electrophoresis (PAGE) and transferred 
to Immobilon-P membranes (Millipore, Bedford, MA). 
Immunoblotting was performed with specific antibodies and 
visualized by using the ECL Western blotting detection kit 
(Amersham, Buckinghamshire, England). 
  Chemotaxis of primary human CD4 T cells was 
performed by using 24-well transmigration chamber plates 
(5μM pore size, Transwell system (Costar, Cambridge, 
MA)). Migration buffer (600 μl) containing no chemokine or 
40nM SDF-1 was added to the lower chamber and CD4 T 
cells were loaded onto the inserts at a density of 1 x 106 
cells/100 μl. Plates were incubated for 1 h at 37˚C, and the 
number of cells migrating into the lower chamber was 
determined by cell count. The percentage of cells migrating 
to medium without chemokine was subtracted from the 
percentage of cells migrating to the medium with SDF-1, to 
calculate the percentage of specific migration. 
Flow Cytometry 
  CD4 T cells were untreated or treated for indicated times 
with gp120 IIIB or gp120 pre-incubated with sCD4. Cells 
then were stimulated with SDF-1 for 1 min at 37˚C and 
then fixed and stained with fluorescent (Oregon Green 514) 
phalloidin according to manufacturer’s instructions 
(Invitrogen). F-actin content was measured by using Flow 
analysis on FACSscan cytometer and using CellQuest 
software. All experiments were performed at least three 
times. 
RESULTS 
gp120 Inhibits SDF-1Induced Chemotaxis But Does 
Not Alter SDF-1Induced CXCR4 Signaling 
  First we tested whether gp120 inhibition of chemotaxis in 
response to SDF-1 was associated with changes in CXCR4 
expression or signaling. For these experiments, we used 
1μg/mL of gp120, which reflects what is likely present in the 
plasma of HIV-infected patients (Cummins NW, Rizza SA, 
Badley AD. How much gp120 is there? JID. In Press). 
Primary human unstimulated CD4 T cells were treated with 
or without soluble gp120 IIIB for 1 to 60 min, and after 
gp120 stimulation, these cells were treated with SDF-1 in a 
chemotaxis chamber, and SDF-1-induced chemotaxis was 
measured. While gp120 significantly inhibits chemotaxis at 
all of these time points (Fig. 1A), it causes only a transient 
decrease in CXCR4 expression at early time points. 
Although receptor expression has normalized by 60 min 
(Fig. 1B), chemotaxis remains inhibited at that time. These 
observations confirm prior observations of gp120 mediated 
downregulation of CXCR4 [5]; however, these data highlight 
a discordance between SDF-1-induced chemotaxis being 
inhibited even after CXCR4 levels have normalized, 
suggesting that factors other than receptor downregulation 
alone are involved. 
 
Fig. (1). gp120 inhibits SDF-1induced chemotaxis of primary 
human resting CD4 T cells. (A) CD4
 T cells were isolated and 
purified (98% pure) and pre-treated with either gp120 (IIIB) 
(1μg/ml) or BSA (1μg/ml) for indicated time to and then the 
percentage of CD4 T cells which underwent chemotaxis in response 
SDF-1 (40nM, 1 hour) was determined. P values were determined 
by Student’s paired t test. (B) Primary human unstimulated CD4 T 
cells were treated with gp120 IIIIB or BSA as described above, and 
expression of CXCR4 was measured by Flow Cytometry. The data 
is representative of three independent experiments. 
  While gp120 does not significantly alter CXCR4 
expression at 60 min, it may still affect signaling, therefore 
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we assessed whether gp120 alters SDF-1–induced 
activation of Erk and Akt. SDF-1 stimulation of CD4 T 
cells resulted in (Fig. 2B) phosphorylation of Erk or Akt that 
was not altered by gp120. gp120 stimulation induces Lck 
phosphorylation regardless of whether cells are co-treated 
with SDF-1  (Fig. 2A). Altogether, these results suggest 
that gp120 can inhibit chemotaxis of CD4 T cells without 
significantly affecting either SDF-1  signaling through 
CXCR4, or affecting CXCR4 expression. 
 
Fig. (2). gp120 does not affect G-protein dependent Erk and 
Akt activation by SDF-1. Purified primary human CD4 T cells 
were treated with SDF-1 and then with gp120 IIIIB (1μg/ml) for 
the indicated times (A) or SDF-1 (40nM) in the presence or 
absence of gp120 IIIB (B). Activation of Akt, Erk and Lck were 
analyzed by immunoblotting with anti-phospho-S473Akt, anti-
phospho-Erk (T280/Y282) and anti-phospho-Y416Src. Total 
amount of Erk and Lck were detected with anti-Erk and anti-Lck. 
The data is representative of three independent experiments. 
gp120 Impairs SDF-1Induced F-Actin Polymerization 
in CD4 T Cells 
  Migration of CD4 T cells towards SDF-1  requires 
cytoskeleton reorganization and cyclic F-actin – 
polymerization and depolymerization [16, 17]. We tested if 
gp120 interferes with SDF-1-induced F-actin – 
polymerization which is measured as an increase in F-actin 
content by specific staining with fluorescent phalloidin [18] 
by measuring F-actin content in primary human CD4 T cells 
following SDF-1 -stimulation in the presence or absence of 
gp120. SDF-1  treatment results in a significant increase in 
F-actin content (determined as a change in mean 
fluorescence) in CD4 T cells (Fig. 3A, B), but pre-treatment 
of CD4 T cells with gp120 decreases SDF-1induced F-
actin polymerization (Fig. 3A, B). To confirm the relevance 
of F-actin polymerization in chemotaxis, we compared F-
actin content in cells which had undergone chemotaxis in 
response to SDF-1 with those which did not (Fig. 3C). 
Those cells which had not undergone chemotaxis had less F-
actin than those which had. Altogether these results 
demonstrate that gp120 impairs cytoskeleton reorganization 
and therefore blocks migration of CD4 T cells in response to 
SDF-1 . 
 
Fig. (3). gp120 inhibits SDF-1induced F-actin polymerization 
in CD4 T cells. (A) Purified primary human CD4 T cells were pre-
treated with either gp120 IIIIB (1μg/ml) for 2 min or BSA, and then 
either left untreated or stimulated with SDF-1 (40nM) for 1 min, 
and cells were analyzed for F-actin content. (B) Pooled results of 
three independent experiments described above (A). P values were 
determined by Student’s paired t test. (C) Primary human 
unstimulated CD4 T cells were separated into two populations 
following chemotaxis in transwell chambers. Cells from upper 
chamber (no chemotaxis) and lower chamber (chemotaxis) were 
analyzed for F-actin content as described above. The data is 
representative of three independent experiments. 
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CD4 is Required for gp120 Effect on SDF-1Induced 
Cofilin Phosphorylation, F-Actin – Polymerization and 
Chemotaxis 
  We next questioned whether the gp120 effect on SDF-
1induced chemotaxis and F-actin polymerization is 
mediated through CD4 or CXCR4. Primary human CD4 T 
cells were pre-treated with either gp120 or gp120 pre-
incubated with soluble CD4 (sCD4); this treatment prevents 
gp120 binding to cell surface CD4 but still allows signaling 
through CXCR4 [19, 20]. Pretreatment of gp120 with sCD4 
completely reversed the inhibitory effect of gp120 on SDF-
1induced chemotaxis and F-actin polymerization (Fig. 
4A, B). 
Fig. (4). CD4 is required for gp120 inhibition of SDF-
1induced chemotaxis. (A) Purified primary human CD4 T cells 
were pre-treated with either gp120 (IIIB) (1μg/ml), BSA (1μg/ml) 
or gp120 (IIIB) (1μg/ml) incubated with sCD4 (1:3) and then 
chemotactic response of CD4 T cells to SDF-1 (40nM, 1 hour) 
cells measured. P values were determined by Student’s paired t test. 
(B) Cells were pre-treated with either gp120 (IIIB) (1μg/ml), BSA 
(1μg/ml) or gp120 (IIIB) (1μg/ml) incubated with sCD4 (1:3) for 2 
min and then stimulated with SDF-1 (40nM) for 1 min, and F-
actin content was measured. The data is representative of three 
independent experiments. 
  Since cofilin is critical to actin remodeling which is 
necessary for chemotaxis, we next assessed whether cofilin 
is phosphorylated following treatment with gp120 (Fig. 5A). 
gp120 induces significant cofilin phosphorylation, which is 
followed by a decrease in total cofilin. This differs from 
what occurs with SDF-1, where early phosphorylation is 
followed by a lesser decrease in total cofilin (Fig. 5B) [12]. 
This gp120-induced phosphorylation of cofilin is Lck-
dependent as demonstrated by its inhibition with the Lck 
inhibitor PP2 (Fig. 5C), suggesting that cofilin is directly or 
indirectly a downstream target of Lck. 
  We next studied primary CD4 T cell chemotaxis in 
response to SDF-1, following gp120 pretreatment in the 
presence or absence of PP2. As suggested by our cofilin 
phosphorylation data, SDF-1-induced chemotaxis is   
 
efficiently inhibited by gp120, yet this inhibition was 
reversed by PP2 (Fig. 5D). Finally, we tested the effect of 
gp120 on SDF-1induced chemotaxis where Lck is absent. 
The effect of gp120 on SDF-1induced chemotaxis was 
studied in Lck deficient Jurkat derivative T cell lines J.CaM 
or J.CaM stably reconstituted with Lck (Fig. 5E). Since Lck 
is required for SDF-1induced chemotaxis [21], it was of 
no surprise that the Lck deficient J.CaM T cells underwent 
chemotaxis weakly in response to SDF-1, however that 
chemotaxis which did occur was not blocked by gp120 
pretreatment. In contrast after Lck expression was 
reconstituted both chemotaxis and its inhibition by gp120 
were restored (Fig. 5E). Altogether, our results indicate that 
gp120 interaction with CD4 receptor induces Lck-dependent 
inhibition of CD4 T cell chemotaxis in response to SDF-1 
and is associated with cofilin phosphorylation. 
DISCUSSION 
  We show that gp120 binding to the CD4 receptor inhibits 
the chemotactic response of CD4 T cells through an Lck 
dependent pathway which inhibits actin cytoskeleton 
reorganization and causes cofilin phosphorylation. This 
observation offers an explanation for prior observations that 
formation of the virologic synapse (VS) due to virion bound 
gp120 interacting with CD4 arrests migration of CD4 T cells 
[22], and causes a localized increase in F-actin [22]. It also 
supports a recently proposed model suggesting that the 
interaction of CD4 T cells with gp120 triggers cytoskeleton 
reorganization in a two step process: first actin polymerizes 
to form a cortical F-actin zone and second, actin 
depolymerization results in formation of an F-actin depleted 
zone underneath the gp120-rich region [23]. 
  The fact that gp120 does not interfere with G-protein 
mediated SDF-1/CXCR4 signaling (Fig. 2B) indicates that 
both gp120 and SDF-1 independently signal through 
CXCR4, likely because each ligand uses a distinct, but 
overlapping, binding sites within the extracellular domain of 
CXCR4 [24]. It is well established that binding of SDF-1 to 
CXCR4 results in phosphorylation of Erk and Akt, yet it is 
less well understood how gp120 signals downstream of 
CXCR4. It has been previously reported that clustering of 
the CD4 and CXCR4 receptors following viral binding 
requires actin cytoskeletal rearrangement, which is mediated 
by Filamin A [25]. In this model both CD4 and CXCR4 are 
required for filamin A binding, which then leads to a RhoA-
ROCK-LIMK mediated phosphorylation of cofilin which 
permits the F-actin reorganization required for receptor 
clustering. In the SDF-1-induced chemotaxis model, 
inhibition of chemotaxis by gp120 is completely reversed by 
sCD4 and by Lck inhibition and/or deficiency, 
demonstrating a requirement for CD4 and Lck upstream of 
cofilin phosphorylation. It would be of great interest to 
determine whether RhoA or another small GTPase is 
activated downstream of Lck, leading eventually to cofilin 
phosphorylation. 
  There has been recent interest in studying the impact of 
cofilin on HIV and vice versa. The first observation being 
that CXCR4 interaction with gp120 results in activation of 
cofilin, resulting in F-actin depolymerization, which 
normally functions as a restriction factor for cellular   
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infection in resting CD4 T cells [26]. Thereafter conflicting 
results have been observed in patient samples, where 
treatment of CD4 T cells with gp120 results in cofilin 
dephosphorylation after 24 hours, but cofilin 
phosphorylation after 15 minutes of treatment with whole 
virus [27]. More recently Nef has been observed to cause 
hyperphosphorylation of cofilin, resulting in an impaired 
chemotactic response of cells to a variety of chemotactic 
stimuli. This effect was due to the known interaction of Nef 
with Pak2, which the authors suggest directly phosphorylates 
cofilin [28]. Results contained in the current report are 
consistent with this existing information, and further increase 
the body of knowledge concerning the regulation of cofilin 
in HIV infection. While gp120 signaling through CXCR4 
causes cofilin dephosphorylation, facilitating infection, 
gp120 interaction with CD4 induces a hyperphosphorylation 
of cofilin as was seen within 1-15 minutes but not following 
overnight incubation with whole virus [25, 27]. In a manner 
similar to that employed by Nef, the gp120:CD4 
hyperphosphorylation of cofilin, results in impaired cellular 
migration. While we have shown this to be CD4 receptor and 
Lck dependent, cofilin is unlikely to be a direct target of 
Lck, and therefore future work will be required to elucidate 
the down stream kinase responsible for cofilin 
 
Fig. (5). Lck is required for gp120 inhibition of SDF-1induced chemotaxis. (A) Purified primary human CD4 T cells were treated 
with either gp120 (IIIB) (1μg/ml) or (B) SDF-1 and analyzed for cofilin phosphorylation over time by immunoblotting with anti-phospho-
S3cofilin. (C) Primary human CD4 T cells were pre-treated with Lck inhibitor PP2 (2μM) for two hours and then treated with gp120 (IIIB) 
(1μg/ml) and analyzed for cofilin phosphorylation over time. (D) Cells were pre-treated with either gp120 (IIIB) or BSA (1μg/ml) for 2 min 
and then chemotactic response to SDF-1 (40nM) in the presence or absence of the Lck inhibitor PP2 was measured in transwell chemotaxis 
chambers. P values were determined by Student’s paired t test. (E) J.CaM T cells and J.CaM T cells stably expressing wild-type Lck were 
pre-treated with either gp120 (IIIB) (1μg/ml) or BSA (1μg/ml) for 2 min and then chemotactic response to SDF-1 (40nM) was measured in 
transwell chemotaxis chambers for 1 hour. Expression of Lck was confirmed by immunoblotting. P values were determined by Student’s 
paired t test. 
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phosphorylation following gp120 triggering of the CD4 
receptor. 
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